Sponsored by the International Journal Human Antibodies
In association with the Integrative Medical Sciences Association
The HAH 2012 scientific programme will include keynote lectures, contributed papers and poster presentations emphasising all key aspects of human antibody and hybridoma technology, applications and engineering.
Scientific Advisory Committee
Programme Chairman:
Professor Mark Glassy (IMSA, San Diego, USA)
Mirek Gorny (New York University School of Medicine, New York, USA)
Zdenka L. Jonak (GlaxoSmithKline, USA)
Henry Lowman (CytomX Therapeutics Inc., South San Francisco, California, USA)
J. Donald Capra (OMRF, USA)
Roberto Burioni (Universita Vita-Salute San Raffaele, Milan, Italy)
Kathy Potter (Southampton University, UK)
Jim Larrick (Panorama Research Inc., USA)
Alois Lang (GeNeuro SA, Geneva, Switzerland)
David P. Humphreys (UCB-Celltech, Slough, UK)
Markus Enzelberger (MorphoSys AG, Martinsried, Germany)
Eszter Nagy (Arsanis GmbH, Vienna, Austria)
Sachdev Sidhu (University of Toronto, Canada)
John Haurum (-star, Cambridge, UK)
Paul Kerr (Fusion Antibodies, Northern Ireland, UK)
Yan Wu (Kadmon Pharmaceuticals LLC, New York, USA)
Bob Kelley (Genentech Inc., South San Francisco, USA)
Torben P. Frandsen (Symphogen A/S, Lyngby, Denmark)
David Naor (The Hebrew University, Jerusalem, Israel)
Alex von Gabain (Intercell AG, Vienna, Austria)
Jody Berry (Becton Dickinson, La Jolla, California, USA)
Manuel Baca (MedImmune Inc., Gaithersburg, Maryland, USA)
Jean-Luc Teillaud (INSERM/Cordeliers Research Centre, Paris, France)
Dale Ludwig (ImClone Inc., New York, USA)
